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We report that a toxic polypeptide retaining the potential to refold upon dislocation from the endoplasmic reticulum (ER)
to the cytosol (ricin A chain; RTA) and a misfolded version that cannot (termed RTA), follow ER-associated degradation
(ERAD) pathways in Saccharomyces cerevisiae that substantially diverge in the cytosol. Both polypeptides are dislocated
in a step mediated by the transmembrane Hrd1p ubiquitin ligase complex and subsequently degraded. Canonical
polyubiquitylation is not a prerequisite for this interaction because a catalytically inactive Hrd1p E3 ubiquitin ligase
retains the ability to retrotranslocate RTA, and variants lacking one or both endogenous lysyl residues also require the
Hrd1p complex. In the case of native RTA, we established that dislocation also depends on other components of the
classical ERAD-L pathway as well as an ongoing ER–Golgi transport. However, the dislocation pathways deviate
strikingly upon entry into the cytosol. Here, the CDC48 complex is required only for RTA, although the involvement of
individual ATPases (Rpt proteins) in the 19S regulatory particle (RP) of the proteasome, and the 20S catalytic chamber
itself, is very different for the two RTA variants. We conclude that cytosolic ERAD components, particularly the
proteasome RP, can discriminate between structural features of the same substrate.
INTRODUCTION
Misfolded and orphan polypeptides in the endoplasmic re-
ticulum (ER) of eukaryotic cells are detected and dispatched
to the cytosol for proteasomal elimination via ER quality
control pathways known collectively as ER-associated deg-
radation (ERAD). Usually, they are extracted from the ER
membrane by a p97/Cdc48p complex (Bays et al., 2001; Ye et
al., 2001; Jarosch et al., 2002a; Rabinovich et al., 2002; Rouiller
et al., 2002; Elkabetz et al., 2004), polyubiquitylated by mem-
brane-bound dislocation complexes (Carvalho et al., 2006;
Denic et al., 2006), and degraded by 26S proteasomes. Al-
though a large number of components required for ERAD in
yeast and mammalian cells has now been identified for a
range of substrates (Meusser et al., 2005; Nakatsukasa and
Brodsky, 2008), it is not clear whether a given cell will
handle different forms of the same soluble substrate in ex-
actly the same way.
To investigate this, we have used the protein cytotoxin
ricin. Native holotoxin normally traffics to the ER lumen of
target mammalian cells (Spooner et al., 2006) where it be-
comes reduced to its cell-binding B chain (RTB) and a struc-
turally native cytotoxic A chain (RTA; Bellisola et al., 2004;
Spooner et al., 2004). RTA is then thought to masquerade as
a misfolded protein in order to co-opt an unknown number
of ERAD components (Wesche et al., 1999; Lord et al., 2005).
Subsequently, RTA is dislocated to the cytosol where it
depurinates 28S rRNA, inhibiting protein synthesis (Endo et
al., 1987). A dearth of lysyl residues in RTA (Hazes and
Read, 1997; Deeks et al., 2002) reduces polyubiquitylation
potential, presumably hampering targeting to proteasomes.
Cytosolic RTA then disengages from ERAD, refolding to a
catalytic conformation, assisted by Hsc70 (Spooner et al.,
2008). These observations led us to probe the requirements
for uncoupling from ERAD by comparing native RTA with
a structurally defective form (RTA; Simpson et al., 1999),
which is known to be a model glycosylated, ubiquitylated
ERAD substrate whose fate depends on the Png1p–Rad23p
complex that acts between Cdc48p and the proteasome (Kim
et al., 2006).
The extreme sensitivity of mammalian cells to ricin makes
identification of the ERAD components exploited by this
toxin very difficult. Because there are many similarities be-
tween yeast and mammalian ERAD (Kawaguchi and Ng,
2007) and because yeast ribosomes are less sensitive to RTA
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toxicity than their mammalian counterparts, we expressed
these RTA variants in the yeast ER lumen by targeting the
nascent proteins with a Kar2 signal peptide. Using biochem-
ical analyses with both toxin forms and survival assays with
native RTA, we identified a requirement for cycling via the
Golgi complex and for the Hrd1p-Hrd3p ERAD dislocation
complex. Although these precytosolic requirements are sim-
ilar for both toxins, we unexpectedly find that the Cdc48p
and proteasome requirements are strikingly different, dem-
onstrating that structural features of an ERAD substrate can
influence its ultimate fate.
MATERIALS AND METHODS
Yeast Strains and Plasmids
A yeast gene knockout collection derived from strain BY4741 (MATa his1,
leu20, met150, ura30) was sourced from Open Biosystems (Huntsville, AL;
Table 1). Other strains used are also listed in Table 1. Cultures were grown in
rich YPDA media or synthetic media containing standard ingredients and 2%
glucose (SD medium), 2% raffinose (SR medium), or 2% raffinose  2%
galactose (SRG medium). Where appropriate, medium lacking uracil and
leucine was utilized. Yeast transformations were achieved by using the lith-
ium acetate/single-stranded DNA/polyethylene glycol method as previously
described (Gietz and Woods, 2002).
Construction of ERAD Substrates and Phenotype
Complementation
RTA is a misfolded protein in which a stretch of five amino acids from
within the active site has been deleted. For screening yeast strains using a
viability assay, RTAE177A was used. This protein contains a minor active site
change and exhibits only sixfold reduced activity (Kim et al., 1992). This slight
attenuation of activity was a safeguard to permit survival should there be a
less than full cotranslational coupling of ER import by the Kar2p signal
peptide in situations where retrotranslocation was completely blocked. In
experiments where RTA stability was measured, the less potent RTAE177D
was used (Chaddock and Roberts, 1993; Allen et al., 2007). Structure determi-
nation has shown that this toxin shows only a subtle change within the active
site cleft (Allen et al., 2007) and can therefore be regarded, like RTAE177A, as
having an essentially native conformation. However, the protein has a 50–
70-fold reduced catalytic activity (Chaddock and Roberts, 1993), and this
permits greater growth of yeast cells and easier visualization of toxin by
SDS-PAGE. For simplicity, both RTAE177A and RTAE177D (essentially native)
toxins are referred to as RTA throughout. PCR was used to fuse the yeast
Kar2p signal sequence with the open reading frames of RTAE177A (Kim et al.,
1992) and RTAE177D (Allen et al., 2007). Fusions were cloned under the
transcriptional control of the GAL1 promoter in a yeast expression vector
derived from pRS316 (Sikorski and Hieter, 1989). A fusion gene encoding
Kar2-RTA with a deletion of five amino acids in the active site that renders
it both inactive and misfolded (Simpson et al., 1999) was similarly cloned
downstream of the GAL1 promoter. In addition, the open reading frame of
RTAE177D lacking a signal sequence was cloned downstream of the GAL1
promoter for cytosolic expression. RTA variants lacking lysyl residues—
RTAE177A(1K) and RTAE177A(0K)—were created using a QuickChange II
Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA). RTAE177A(1K)
was constructed by changing Lys239 to Arg using the following oligonuc-
leotides: 5-gccgatgatatattccccagacaatacccaattataaac-3/5-gtttataattgggatttgtc-
tggggaatatatcatcggc-3. RTAE177A(0K) was generated by changing Lys4 in
RTAE177A(1K) to Arg using the oligonucleotides 5-caaagacgtaatggttccagat-
tcagtgtgtacgatgtg-3/5-cacatcgtacacactgaatctggaaccattacgtctttg-3. Gener-
ation of a plasmid for the expression of a catalytically inactive Hrd1p involved
altering Cys399 to Ser (Bordallo and Wolf, 1999) and cloning both the wild-type
and mutant versions in an integrating vector with a LEU2 selective marker.
Pulse-Chase Analysis
Yeast cells carrying plasmids that expressed Kar2p-RTA fusions under con-
trol of the GAL1 promoter were grown overnight at 30°C in SR medium. Cells
(1.48  108) were harvested and washed before being incubated (30 min,
30°C) in inducing SRG medium lacking methionine. After addition of 280
Ciml1 [35S]methionine/cysteine the cells were incubated (20 min, 30°C),
after which excess unlabeled methionine and cysteine were added. Chase
samples were taken at time zero and various time points thereafter (see figure
legends). Metabolically labeled RTA was immunoprecipitated from cell ly-
sates as described previously (Simpson et al., 1999). Products were analyzed
by reducing SDS-PAGE and autoradiography and were quantified using
TotalLab software (Newcastle upon Tyne, United Kingdom). Where temper-
ature-sensitive strains were used, cells were grown at the permissive temper-
ature for growth and shifted to the restrictive temperature for 2 h before the
start of the radioactive pulse. Where required, cells were incubated in me-
dium containing inhibitors of protein trafficking (300 M brefeldin A [BFA]),
proteasomal degradation (20 M clasto-lactacystin -lactone [cL-l]) or N-
glycosylation (25 gml1 tunicamycin) for 30 min before pulse-chase analy-
sis, and the inhibitors were maintained throughout the pulse chase. To trap
any ubiquitylated intermediates, expression of ER-targeted RTA or RTA was
induced by growth in galactose medium for 2 h in the presence or absence of
cL-l. Cells were then pulse-labeled for 20 min, and cell lysates were prepared as
before but with the addition of 10 mM N-ethyl maleimide in the initial lysis
buffer.
Growth Sensitivity to Ricin A Chain
Yeast cells expressing a fusion of the Kar2 signal peptide and RTAE177A were
grown overnight in liquid SR medium lacking uracil. Tenfold serial dilutions
of cells from 106 to 101 were plated on S-galactose plates (2% galactose)
lacking uracil to induce expression and on S-glucose plates (2% glucose) as
controls. Plates were incubated at 30°C for 4 d and examined for growth
differences.
Table 1. Yeast strains used in this study
Strain Genotype Source/Reference
BY4741 MATa his1, leu20, met150, ura30 Open Biosystems
cdc48-1 cdc48-1, prc1-1, ura3-52, ade2-101, lys2-801, can1-100 Ye et al. (2001)
cdc48-3 cdc48-3, prc1-1, leu2-3,-112, ura3-52, ade2-101 Ye et al. (2001)
SNY1025 MAT scj1::TRP1 ura3 leu2 trp1 his3 lys2 suc2 Heiligenstein et al. (2006)
SNY1028 MAT jem1::LEU2 ura3 leu2 trp1 his3 lys2 suc2 Heiligenstein et al. (2006)
SNY1026-7A MAT jem1::LEU2 scj1::TRP1 ura3 leu2 trp1 his3 lys2 suc2 Heiligenstein et al. (2006)
KRY167 ade2-1 ura3-1 his3-11,15 leu2-3,112 trp1-1 can1-100 prc1-1 (pep4::URA3) Gillece et al. (1999)
JN284 MAT ura3-52, leu2 (-3,-112), his7-2, ise1 Gaber et al. (1989); Vogel et al. (1993)
YPH 499 MATa ura3-52 leu2-D1 his3-D200, trp1-D63 lys2-801 ade2-101 Ghislain et al. (1993)
CMY 763 MATa cim3-1, ura3-52 leu2-D1 his3-D200 Ghislain et al. (1993)
CMY 765 MATa cim5-1, ura3-52 leu2-D1 his3-D200 Ghislain et al. (1993)
DHY9 MAT ura3-52 lys2-801 ade2-101 trp1-1 his3-200 leu2-1 Springer et al. (2000)
RSY188 DHY9, emp24::HIS erv25::HIS3 erp1::TRP1 erp2::HIS3 erp3::loxP
erp4::loxP erp5::loxP erp6::loxP-Kanr-loxP
Springer et al. (2000)
RSY263 MAT sec12-4 ura3-52 Kaiser and Schekman (1990)
RSY281 MAT sec23-1 ura3-52 his4-619 Kaiser and Schekman (1990)
SUB62 MATa his3-200 lys2-801 leu2-3,112 trp1-1 ura3-52 Rubin et al. (1998)
Rpt2RF MATa his3-200 lys2-801 leu2-3,112 trp1-1 ura3-52, rpt2RF Rubin et al. (1998)
Rpt4R MATa his3-200 lys2-801 leu2-3,112 trp1-1 ura3-52, rpt4R Rubin et al. (1998)
Cl3-ABYS-86 MAT pra1-1 prb1-1 prc1-1 cps1-3 ura35 leu2-3, 112 his Heinemeyer et al. (1991)
pre1-1 Cl3-ABYS-86, pre1-1 Heinemeyer et al. (1991)
S. Li et al.
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RESULTS
ER Import Is a Prerequisite for the Degradation of Ricin
A Chain
Pulse-labeled ER-directed RTA has nonglycosylated (g0)
and singly (g1), and doubly glycosylated (g2) forms: in
contrast, ER-targeted RTA occurs primarily as g0 with a
minor fraction of g1 (Figure 1A), suggesting that ER-directed
RTA folds rapidly (Allen et al., 1995). Both disappeared
during a 1-h chase with unlabeled amino acids (Figure 1B),
not by turnover in vacuoles, nor by secretion, because dis-
appearance was unaltered in a yeast strain lacking vacuolar
proteinase A (Pep4p) that is required for activation of many
vacuolar proteases (Figure 1C), and both were absent from
extracellular medium (not shown). In marked contrast, RTA
expressed cytosolically remained stable (Figure 1B) unlike a
previously characterized cytosolic CPY*-GFP fusion (Medi-
cherla et al., 2004). Thus ER import is a prerequisite for RTA
degradation.
Misfolded and Native RTAs Require the Hrd1-Hrd3p
Complex for Dislocation
RTA severely hampers yeast cell growth when expressed
within the ER lumen in a form that is competent to acquire
a native conformation after its retrotranslocation to the cy-
tosol (Allen et al., 2007). This effect on viability is due to A
chain–catalyzed depurination of the EF-2–binding site on
the ribosome and the consequent inhibition of protein syn-
thesis (Endo et al., 1987), even though most of the dislocated
toxin is proteolysed in the cytosol (Simpson et al., 1999). Two
major membrane-associated E3 ubiquitin ligase complexes
(Hrd1p–Hrd3p and Doa10p) play roles in ERAD dislocation
(Carvalho et al., 2006; Denic et al., 2006). Open Biosystems
yeast knockout strains with deletions of genes encoding
proteins associated with these complexes were transformed
with RTA and examined by viability assay on both nonin-
ducing (glucose) and inducing (galactose) plates (Figure 2A,
Table 1) and by monitoring RTA stability by pulse-chase
analysis (Figure 2B). Genetic deletions that conferred growth
advantages correlated with acquired stability on pulse-
chase. RTA was also stabilized in hrd1 but not in doa10
yeast strains (Figure 2C), as shown in a previous study (Kim
et al., 2006). The need for Hrd3p, Usa1p, and Der1p is
consistent with the critical involvement of Hrd1p, because
these cofactors form a near stoichiometric complex even
though Der1p itself is only involved in the turnover of a
subset of luminal (or ERAD-L) substrates (Knop et al., 1996;
Taxis et al., 2003; Hitt and Wolf, 2004; Carvalho et al., 2006).
We also note relatively minor roles for Usa1p, which is
required for optimal activity of the Hrd1-Hrd3 complex
(Carroll and Hampton, 2010); the membrane-integral Cue1p,
which recruits (Biederer et al., 1997) and activates Ubc7p
(Bazirgan and Hampton, 2008); and Ubx2p, which couples
the Hrd1 complex to the cytosolic Cdc48 complex (Wilson et
al., 2006).
Retrotranslocation of Native RTA Does Not Depend on
an Active Hrd1p or on Lysyl Ubiquitylation
Because the Hrd1 complex is required, we examined the
importance of the catalytic activity of this E3 ubiquitin ligase
for RTA dislocation (Figure 3). Expression of either wt
Hrd1p or the catalytically inactive Hrd1C399S (Bordallo and
Wolf, 1999) in a hrd1 strain restored the toxicity of RTA,
resulting in an inhibition of growth (Figure 3A). That
Hrd1C399S lacked catalytic activity was also confirmed by its
ability to stabilize CPY* (Figure 3B). The dislocation of RTA
must therefore require structural features of Hrd1p rather
than its catalytic activity. We further show that dislocation of
the native toxin does not involve ubiquitylation of lysyl
residues because changing one or both endogenous lysines
to arginine does not alter the requirement for Hrd1p (Figure
3C). Eventual fate in the cytosol is also independent of
canonical ubiquitylation because the turnover of native RTA
is identical to that of RTA(0K) (Figure 3D). We conclude that
both RTA variants serve as ERAD-L substrates in a process
that, for the native toxin, is independent of its lysine content
and does not require the catalytic activity of Hrd1p.
Access to the Golgi Is Essential for Dislocation of Both
Forms of RTA
Active ER–Golgi transport is required for a number of yeast
ERAD substrates (Caldwell et al., 2001; Vashist et al., 2001;
Haynes et al., 2002; Vashist and Ng, 2004). We therefore
Figure 1. RTA is degraded after import into the ER lumen. Two
RTA variants were immunoprecipitated from detergent soluble ex-
tracts prepared after a pulse of radiolabeled [35S]methionine/cys-
teine with or without a subsequent chase of unlabeled amino acids
for the times indicated. Samples were analyzed by SDS-PAGE and
fluorography, and fluorograms were quantified using TotalLab soft-
ware. (A) Immunoprecipitated pulse-labeled RTA (lanes 3 and 4)
and RTA (lanes 5 and 6). Lanes 1 and 2, in vitro–translated mature
RTA (SP) and Kar2p signal peptide-RTA fusion (SP). g0, non-
glycosylated; g1, singly glycosylated; g2, doubly glycosylated; Tn,
tunicamycin; , unprocessed RTA. (B) Pulse-chase kinetics of ER-
targeted RTA and cytosolic RTA. (C) Pulse-chase kinetics of the two
ER-targeted RTAs in KRY167 (a pep4 deletion strain).
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tested the effects of the fungal metabolite BFA that fuses
endosomal compartments and merges the Golgi and ER,
reversibly blocking early but not late protein transport steps
in the yeast secretory pathway (Graham et al., 1993). In the
drug-sensitive strain JN284 (Vogel et al., 1993), BFA treat-
ment stabilized both RTA and RTA, compared with cells
treated only with the BFA vehicle ethanol (Figure 4A).
ER-to-Golgi transport requires COPII vesicles. In a mutant
containing a temperature-sensitive lesion in Sec12p, a gua-
nine nucleotide exchange factor of the COPII-associated GT-
Pase Sar1p (Barlowe and Schekman, 1993), RTA was stabi-
lized at the restrictive temperature (37°C, Figure 4B), but not
at the permissive temperature (24°C). Structurally native
RTA was also stabilized at the restrictive temperature (Fig-
ure 4C) but not at the permissive temperature (24°C, not
shown). Likewise, in a strain bearing a temperature-sensi-
tive lesion in Sec23p, a GTPase-activating protein that stim-
ulates Sar1p (Duden, 2003), RTA was rendered stable at the
restrictive temperature (Figure 4C) but not at the permissive
temperature (24°C, not shown).
Finally, for native RTA, we investigated the p24 mediators of
ER-to-Golgi trafficking (Springer et al., 2000). A particularly
striking growth advantage was seen in cells lacking Erp2p after
induction of RTA expression (Figure 4D, top). Individual de-
letion of each of the other p24 family members (ERP1, ERP3-6,
EMP24 and ERV25) and additional proteins localized to COPII-
coated ER exit sites did not permit such survival (Table 2).
Expression of functional Erp2p protein in the erp2 strain
restored normal RTA toxicity (Figure 4D, middle). Curiously,
deletion of all eight p24 family genes gave only a slight growth
advantage compared with the congenic parental strain (Figure
4D, bottom). This is consistent with previous observations
showing that individual p24 proteins act as negative regulators
of COPII vesicle entry for different substrates (Springer et al.,
2000). As expected, pulse-labeled RTA was stabilized in the
erp2 strain (Figure 4E), as indeed was RTA, pointing to a
common requirement for Erp2p function for both these sub-
strates (Figure 4F).
Role of Luminal and Cytosolic Chaperones
ERAD of many misfolded proteins is aided by DnaJ do-
main–containing Hsp40 cochaperones that interact with the
ER luminal chaperone Kar2p/BiP, improving their solubil-
ity in the ER lumen (Nishikawa et al., 2001). One way of
demonstrating indirectly any role of Kar2p in RTA retro-
translocation is to examine single and double knockouts of
Figure 2. RTA variants dislocate via the Hrd1p–Hrd3p–Der1p complex. (A) Viabilities of yeast strains harboring RTA were assessed by
spotting dilutions of cells on noninducing (glucose, left) and inducing (galactose, right) media after growth at 30°C for 5 d. WT, wild-type
BY4741. (B) Typical immunoprecipitates of pulse-chase samples revealed by SDS-PAGE/fluorography (gel slices). The associated mean
quantitations (1 SD) of native RTA in selected strains are presented graphically, where n  4 (WT, hrd1, hrd3, ubx2, and ubc7), 3
(der1), or 2 (usa1, cue1, and doa10). Overlapping error bars have been omitted for clarity. (C) Pulse-chase analysis of RTA in WT (left,
top), hrd1 (middle), and doa10 strains (bottom) and their quantitations (right, graph). In all cases quantitations reflect the sum of all RTA
bands in each lane (graphs).
S. Li et al.
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Kar2p-interacting Hsp40s, by viability testing. The single
deletion Hsp40 jem1 mutant was as sensitive to RTA ex-
pression as wild-type cells (Figure 2A, Table 2). However,
upon extended growth (7 d), a scj1jem1 double knockout
showed slightly increased survival (not shown). This sug-
gests that these Kar2p-interacting Hsp40s in conjunction are
required for optimal toxicity, confirming similar findings for
the viral A/B toxin K28 (Heiligenstein et al., 2006). In the
context of jem1 this requirement was not obvious presum-
ably because Scj1p could largely substitute for the other
Hsp40. In a strain missing the lectin chaperone Yos9p (Fig-
ure 2A), which also interacts with Kar2p (Denic et al., 2006),
or Mnl1p, an ER mannosidase implicated in glycoprotein
destruction (Table 2), RTA remained able to retrotranslocate,
inhibiting protein synthesis and therefore cell growth to the
same extent as observed in the congenic strain. We conclude
that although RTA requires multiple Kar2p cochaperones
for optimal retrotranslocation, it does not show an absolute
requirement for proteins typically regarded as part of the ER
glycoprotein surveillance machineries.
In principle, acquisition of a catalytic conformation by
dislocated cytosolic RTA could be accomplished by sub-
strate (ribosome)-mediated refolding (Argent et al., 2000), by
spontaneous refolding (Rodighiero et al., 2002) or by inter-
actions with cytosolic components such as chaperones
(Spooner et al., 2008). Because chaperones can also provide
routes to the proteasome (Arndt et al., 2007), knockout of
these proteins and/or their cochaperones might alter the
sensitivity of the yeast cells expressing toxin. We therefore
examined members of the gene knockout library lacking
cytosolic chaperones or their cochaperones for survival after
RTA expression. No clear growth advantage was seen for
cells lacking individual Hsp40, Hsp70, and Hsp90 family
members or Hsp70 and Hsp90 cochaperones (Table 2). How-
ever, as for ER chaperones, redundancy of cytosolic chaper-
ones might obscure their roles when examined in the context
of single knockouts.
Cdc48p Is Required for the ERAD of Misfolded RTA But
Not for Native RTA
Cdc48p functions in a cofactor dependent manner in the
recruitment of polyubiquitylated proteins that are destined
for degradation. Because it acts between ubiquitylation and
proteasomal degradation it is generally assumed that differ-
ent ERAD pathways merge here (Ye et al., 2001, 2003; Bar-
Nun, 2005). Because loss of CDC48 is lethal, we examined
the stability of the RTA variants when expressed in condi-
tional cdc48 mutants: the cold-sensitive cdc48-1 and the tem-
perature-sensitive cdc48-3 (Ye et al., 2001; Jarosch et al.,
2002b). Predictably, RTA showed a strong requirement for
Cdc48p, being stabilized at 23°C in the cold-sensitive strain
and at 37°C in the temperature-sensitive strain (Figure 5A).
However, no obvious Cdc48p dependence was seen in the
case of native RTA (Figure 5B). This surprising finding is in
contrast to the Cdc48p requirement observed when RTA is
retrotranslocated from the ER of tobacco cells (Marshall et
Figure 3. RTA dislocation and fate are not
mediated by ubiquitylation of lysyl residues.
(A) Top, viabilities of WT and hrd1 strains
expressing RTA on noninducing (glucose) and
inducing (galactose) media. Lower panel: via-
bilities of WT and hrd1 strains expressing
RTA after complementation, as appropriate,
with wild type (WT) or catalytically inactive
Ubc7p or Hrd1p on noninducing (glucose) and
inducing (galactose) media. (B) Imunoprecipi-
tates of pulse-chase samples of CPY* in the
Open BioSystems CPY knockout strain (PRC1)
overexpressing either wild-type HRD1 (top) or
Hrd3C399S (middle), and associated quantita-
tions (bottom, graph). (C) Viabilities of WT
and the indicated mutant strains expressing
RTA variants lacking one (RTA(1K)) or both
(RTA(0K)) endogenous lysyl residues on non-
inducing (glucose) and inducing (galactose)
media. (D) RTA fate is independent of lysine
content. Typical immunoprecipitates of pulse-
chase samples of RTA (top) and RTA(0K)
(middle) and their quantitations (bottom, graph);
n  2.
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al., 2008). In plant cells, the ERAD pathway remains poorly
defined although a number of plant-specific features have
been recognized (Di Cola et al., 2005). We speculate that a
Cdc48p requirement in plants may be needed in tissues
where ribosome inactivating proteins are normally made in
order to ensure a tighter coupling of extraction and degra-
dation to prevent autointoxication of ribosomes. Tobacco
leaves are known to express a RIP (termed TRIP; Sharma et
al., 2004).
Npl4p is a Cdc48p cofactor that, along with its partner
Ufd1p, recognizes polyubiquitylated ERAD substrates.
RTA was partially stabilized in a npl4 strain, whereas
native RTA was not (Figure 5C). Furthermore, we saw no
growth advantage in npl4 cells expressing native RTA (Fig-
ure 5D). Thus in yeast, polyubiquitylation may not be im-
portant for the dislocation of native RTA, a view that is
consistent with our earlier observations that the ubiquitin
ligase activity of Hrd1p is not required for this protein and
that RTA variants lacking lysyl residues still retrotranslocate
and disappear (Figure 3). It is further apparent that, al-
though a tiny proportion of the native RTA can be trapped
as monoubiquitylated g0 and g1 species in the presence of
the proteasome inhibitor cL-l, polyubiquitylated interme-
diates cannot be detected (Figure 5E). In contrast there is
evidence of some polyubiquitylated RTA (Figure 5E), find-
ings that are compatible with the Cdc48 complex–mediated
dislocation of this misfolded substrate observed here (Figure
5, A and C) and previously (Kim et al., 2006).
The Proteasome Determines the Fate of the RTA Variants
Although efficient degradation of RTA requires the Png1p–
Rad23p proteasomal receptor complex (Kim et al., 2006),
deletion of PNG1 or RAD23 did not confer growth advan-
tage to cells expressing RTA (Figure 2A). This suggests that
the native toxin can evade this proteasomal receptor com-
plex, pointing perhaps to different proteasomal interactions
of RTA and RTA. To investigate this, we examined the RTA
variants in yeast carrying defined mutations (Rubin et al.,
1998) in the Walker motifs of the six AAA-ATPase Rpt
subunits of the 19S proteasomal regulatory particle (RP).
Degradation of RTA showed a marked requirement for
Rpt2p ATPase activity, but not for the ATPase activities of
the other Rpt subunits (Figure 6A). The glycosylated forms
of RTA disappeared selectively over time, suggesting ex-
posure to cytosolic peptide:N-glycanase (Png1p). Because
Rpt2p allows access of proteasomal substrates to the axial
core of the proteasome (Kohler et al., 2001), where the pro-
teolytic activities reside, this suggests that RTA is normally
degraded by the proteasome. In support of this, the disap-
pearance of RTA was significantly retarded after treatment
of the drug-sensitive JN284 strain (Gaber et al., 1989) with
the proteasomal inhibitor clasto-lactacystin -lactone (Fig-
ure 6C). It was also stabilized in a pre1-1 mutant (Figure 6D)
in which the core 4 catalytic subunit of the proteasome is
defective (Heinemeyer et al., 1991).
By contrast, native RTA dislocates in a process involving
the 19S proteasome cap protein Rpt4p (Figure 6B), which
can extract some ERAD substrates from the ER (Lipson et al.,
2008). However, it shows no obvious requirement for the
other Rpt subunits, Ubr1p (the N-recognin E3 ligase associ-
ated with Rpt6p; Xia et al., 2008; Figure 1A) or the protea-
some core itself (Figure 6, C and D). Native RTA was not
selectively deglycosylated (Figure 6B), consistent with our
observation that a PNG1 deletion had no discernable effect
Figure 4. RTA dislocation requires Golgi
transport. (A) Pulse-chase kinetics of the indi-
cated RTAs in the drug sensitive yeast strain
JN284. Cells treated with solvent alone (top;
EtOH, ethanol) and cells treated with 300 M
BFA dissolved in EtOH (middle) and their
quantitations of the amount of immunopre-
cipitated RTA as measured by densitometry
and expressed as a percentage of the total RTA
present at the end of the pulse (bottom, graph).
(B) Pulse-chase of RTA in a sec12 mutant.
Top, permissive temperature; bottom, restric-
tive temperature. (C) Pulse-labeled RTA (top)
in sec12 (middle) and sec23 strains (bottom).
(D) Top, viabilities of wild-type (WT) and
erp2 cells expressing RTA on inducing me-
dium (galactose); middle, viabilities of WT and
erp2 strains expressing RTA after comple-
mentation, as appropriate, with vector or wt
Erp2p on inducing (galactose-Ura-Leu); and
bottom, viabilities of WT DHY9 and p248
yeasts expressing RTA on inducing (galactose)
medium. (E) Pulse-chase of RTA in WT strain
(top) and in erp2 (middle) and quantitations
as described for A (bottom; n  4 or 5 1 SD).
(F) Pulse-chase of RTA in wild-type strain
(top) and in erp2 cells (bottom).
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on the native protein (Figure 2A). Finally, RTA degradation
is independent of ubiquitylation because RTA and RTA(0K)
exhibit identical kinetics of turnover in pulse-chase analyses
(Figure 3D). It remains unclear what protease or pathway
removes the bulk of this protein in the cytosol. Nevertheless,
it is evident that at least a fraction of dislocated RTA can
recover ribosome-inactivating ability because growth is se-
verely affected upon toxin expression in the ER (Figure 2A).
DISCUSSION
Through the use of a relatively small number of luminal
ERAD substrates a map of ERAD-L components has emerged
(Carvalho et al., 2006). Glycoprotein substrate recognition by
these pathways is currently being unraveled by defining
critical glycan structures in positions of the substrate where
overall protein folding and stability can be monitored (Spear
and Ng, 2005; Xie et al., 2009). However, it remains unclear
how a common substrate that presents ERAD-detectable
motifs in more than one location is handled. We have there-
fore studied the fate of a newly made native and misfolded
toxin in order to highlight similarities and differences in
their handling by ERAD constituents. Such a study also
probes the requirements for the uncoupling that must occur
before reactivation of native toxin in the cytosol. Our data
reveal that the yeast ERAD system can discriminate between
two subtly different forms of this substrate, showing that
although the steps in preparation for retrotranslocation are
generally similar, the downstream cytosolic stages are strik-
ingly different (Figure 7).
RTA inhibits yeast cell growth dramatically (Allen et al.,
2007) through the catalyzed depurination of the sarcin-ricin
domain of 26S rRNA that results in ribosome inactivation
and the inhibition of protein synthesis (Endo et al., 1987). By
monitoring survival of otherwise sensitive yeast cells,
and/or by analyzing acquired biochemical stability of the
toxin substrate, we tested a range of strains lacking or car-
rying defects in many known ERAD components. RTA was
also expressed in a form that is unable to acquire its native
structure, either before or after dislocation to the cytosol
(Simpson et al., 1999). The fate of this RTA was monitored
by following its kinetics of degradation in selected strains of
yeast.
For dislocation to the cytosol, both forms of RTA need
ongoing traffic to the Golgi and they show a specific require-
ment for Erp2p, a protein of the p24 family that has a poorly
understood role in bidirectional transport (cycling) between
the ER and Golgi. Other erp strains, including the p248
that lacks all eight p24 genes (Springer et al., 2000), exhibit
severe growth inhibition when expressing ER-targeted RTA.
The p24 proteins are proposed to act as negative regulators
of COPII vesicle entry for different substrates (Springer et al.,
2000), where individual p24-COPII complexes preclude en-
try of specific cargoes into transport vesicles unless they
display high affinity for budding components. It follows,
however, that in the absence of all the members of this
family, RTA would have unfettered access to budding ves-
icles and may recycle by default. A similar dependency on
COPII-associated proteins has been reported for the Erv29p-
dependent ER–Golgi transport of CPY* (Haynes et al., 2002),
suggesting that it is the cycling of the substrate that is
important. As with other examples of ERAD substrates that
cycle at the ER–Golgi interface (Caldwell et al., 2001; Vashist
et al., 2001; Haynes et al., 2002; Vashist and Ng, 2004), RTA
lacks a C-terminal HDEL sequence so the mechanism of
retrieval remains unknown.
Table 2. Growth characteristics of the gene deletion library members
screened for survival after induced expression of ER–targeted RTA
Gene deletion Growth
advantage
(fold)aStandard name Systematic name
Dislocation complex proteins
CUE1 YMR264W 10–100
UBC7 YMR022W 10–100
HRD1 YOL013C 1000
DOA10 YIL030C nme
HRD3 YLR207W 1000
USA1 YML029W 100
DER1 YBR201W 1000
ER-Golgi transport
ERP1 YAR002C-A nme
ERP2 YAL007C 10,000
ERP3 YDL018C nme
ERP4 YOR016C nme
ERP5 YHR110W nme
ERP6 YGL002W nme
EMP24 YGL200C nme
ERV25 YML012W nme
ERV29 YGR284C nme
ERV41 YML067C nme
ERV46 YAL042W nme
ERV14 YGL054C nme
EMP46 YLR080W nme
EMP47 YFL048C nme
ER luminal chaperones
YOS9 YDR057W nme
MNL1 YHR204W nme
JEM1 YJL073W nme
CNE1 YAL058W nme
Cytosolic chaperones and
cochaperones
HLJ1 YMR161W nme
ZUO1 YGR285C nme
APJ1 YNL077W nme
YDJ1 YNL064C nme
SSA1 YAL005C nme
SSA2 YLL024C nme
SSA3 YBL075C nme
SSZ1 YHR064C nme
SSE1 YPL106C nme
SNL1 YIL016W nme
STI1 YOR027W nme
HSC82 YMR186W nme
HSP82 YPL240C nme
CPR6 YLR216C nme
CPR7 YJR032W nme
SBA1 YKL117W nme
AHA1 YDR214W nme
HCH1 YNL281W nme
Proteasome and associated
proteins
UBR1 YGR184C nme
RPN10 YHR200W nme
SEM1 YDR363W-A nme
UBP6 YFR010W nme
UMP1 YBR173C nme
PNG1 YPL096W nme
RAD23 YEL037C nme
RAD4 YER162C nme
DSK2 YMR276W nme
Cdc48p and its binding proteins
NPL4 YBR170C nme
DOA1 YKL213C nme
OTU1 YFL044C nme
SHP1 YBL058W nme
UBX2 YML013W 10
Signal peptidase complex
SPC1 YJR010C-A nme
SPC2 YML055W nme
a nme, no measurable effect.
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Both RTAs show a common requirement for the central
Hrd1p–Hrd3p–Der1p ubiquitylation complex, supporting
the view that the structurally native RTA can pose as an
ERAD-L substrate. The requirement for Hrd1p reflects its
structural role and is not related to canonical ubiquitylation
because it is observed even with a catalytically inactive
Hrd1p and when the native toxin lacks all internal lysyl
residues. This lends further support to the idea that this
Hrd1–Hrd3–Der1 complex may not only serve as a focal
point for the recruitment of luminal and cytosolic ERAD
components, but that it may constitute the core of a mem-
brane-spanning retrotranslocon (Gauss et al., 2006). The
lesser requirement for the membrane anchor Cue1p suggests
that a poorly ubiquitylated substrate like RTA might also
dislocate through mobile, nonanchored Hrd1–Hrd3p com-
plexes. RTA becomes more heavily glycosylated than RTA,
presumably because in the more structurally defective toxin,
the two N-glycan sequons have had prolonged exposure to
oligosaccharyl transferase. For the weakly glycosylated na-
tive RTA, we observed no dependence on calnexin or on the
intermediaries that extricate glycosylated substrates for pas-
sage to the E3 ligase complex (e.g., the mannosidase-like
protein of the ER, Mnl1p). Furthermore, there is no clear role
for the Yos9p lectin component of the Hrd1p complex either.
It is known that the OS-9 mammalian ortholog of Yos9p can
bind to both glycosylated and nonglycosylated ERAD sub-
strates to deliver them to SEL1L (Hrd3p; Christianson et al.,
2008; Alcock and Swanton, 2009). OS-9 thereby acts as a kind
of gatekeeper to the HRD1 complex in mammalian cells. In
the absence of a role for Yos9p in the ERAD of RTA in yeast
cells, it remains unclear precisely how this substrate is de-
livered to the central Hrd1p–Hrd3p complex. Furthermore,
the ubiquitin ligase that monoubiquitylates RTA has not
been identified and any role for Sec61p is also unresolved at
this time.
After convergence at the Hrd1p–Hrd3p–Der1p complex,
RTA then requires the 19S proteasome cap subunit Rpt4p
that has been associated with extracting CPY* from the ER
Figure 5. Cdc48p and its cofactor Npl4 are required for dislocation of misfolded RTA but not for native RTA. (A) Pulse-chase analyses at
the restrictive temperatures of cold-sensitive cdc48-1 and temperature-sensitive cdc48-3 strains. Immunoprecipitates of misfolded RTA (A)
or RTA (B) are shown. (A and B) Bottom panels, quantitations of the radiolabeled protein remaining at each time point and expressed as a
percentage of the RTA present at the end of the pulse; n  2 or 3; bars, 1 SD. (C) Pulse-chase analysis of misfolded RTA and RTA in WT
and in npl4. Bottom panels, quantitations as described for A and B. (D) Viabilities of wild-type (WT) and npl4 expressing RTA grown on
noninducing (glucose, left) and inducing (galactose, right) medium. (E) Expression of RTA and RTA was induced for 2 h in the presence
and absence of cL-1. RTA variants were immunoprecipitated (IP) from cell extracts prepared in the presence of 10 mM N-ethyl maleimide.
Proteins were identified by immunoblot (IB) for ubiquitin (left) and RTA variant (right). RbIgH, rabbit immunoglobulin heavy chain.
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membrane (Lipson et al., 2008). However, this phase of the
toxin ERAD process shows no obvious requirement for
other Rpt subunits including Rpt2p (the base subunit of the
cap that can open the proteolytic chamber; Kohler et al.,
2001) and does not involve Cdc48p, Ubr1p (an N-recognin
E3 ligase associated with Rpt6p; Xia et al., 2008), or rather
curiously, the proteasome core itself. The effect of rpt4 on the
ERAD of native RTA is probably not related to a general
unfolded protein response (UPR) effect (Lipson et al., 2008)
because this defective RP subunit has a clear consequence on
the ERAD of native RTA, but it has no effect on the ERAD of
RTA. It is not unreasonable therefore to speculate that in
yeast, native RTA is dislocated without a polyubiquitin tag
in a process facilitated by a specific base subunit of the
proteasome cap.
In the disposal of RTA, an essentially similar substrate
save for a short internal deletion that renders it incapable of
attaining correct native structure, there is a contrary and
very noticeable involvement of Cdc48p, Npl4p, the Png1p–
Rad23p proteasomal receptor complex, Rpt2p, and the pro-
teasome core. Such a profile suggests that RTA behaves as
a classical ERAD substrate, most likely extracted by the
Cdc48 complex as a polyubiquitinated protein that is then
deglycosylated in the cytosol by peptide:N-glycanase and
degraded in the proteasome after gating interactions with
Rpt2p.
The site or number of lesions that lead to recognition by
ERAD components clearly influences downstream path-
ways. RTA presents as an ERAD-L substrate, most likely
through structural alterations that involve interaction of a
Figure 6. Native RTA avoids proteasomal degradation. Top panels, pulse-chase of RTA (A) and RTA (B) in WT (SUB62) and rpt1-6 mutant
strains. Bottom panels, overlapping error bars have been omitted for clarity. (C and D) Pulse-chase analysis of RTA and RTA from JN284
cells treated with DMSO (vehicle) or DMSO/lactone cL-1 (C) and pulse-chase analysis of CPY*, RTA, and RTA in a pre1-1 proteasomal core
mutant strain and corresponding WT (cl3-ABYS-86) (D). Bottom panels in C as in A and B.
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C-terminal hydrophobic patch in this protein with ER
lipids (Mayerhofer et al., 2009). In a normal mammalian
cellular intoxication this patch is occluded by RTB (Simp-
son et al., 1995) until revealed by reduction of the holo-
toxin in the ER (Spooner et al., 2004). However, after
dislocation, native RTA is handled very differently to
RTA, which contains this same hydrophobic interface
together with an internal lesion that affects its folding. We
propose that engagement or otherwise with Cdc48p de-
termines subsequent presentation of RTA to the protea-
some, whereupon ATPase subunits of the proteasome RP
discriminate between the two toxin forms. The ability of
native RTA to evade the proteasome core and gain activ-
ity shows that the fate of a protein dislocated by Hrd1p-
dependent processes is not necessarily destruction. We
conclude that interactions with Cdc48p and the manner of
toxin presentation to the proteasome RP permit an unex-
pected divergence in fate on the cytosolic face of the ER
membrane that is distinct from the Doa10p scrutiny of
cytosolic proteins (Metzger et al., 2008).
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